Poster SessionBackground: Higher recurrence rates have been reported among Asian patients transplanted for hepatocellular carcinoma (HCC). It is not clear if these results are due to a different biological behavior of the tumor or to a different modality of patient management before liver transplantation (LT). The main aim of the present study is to analyze the prognostic factors for post-LT HCC recurrence in a cohort of Asian and European patients, with the intent to analyze the relative importance of tumor-related and management-related factors. Methods: Two hundred seventy-three HCC patients transplanted from January 1999 to March 2009 were analyzed. Patients were followed up for a period of 2 years. One hundred sixteen patien...
Background: Risk factors of early and late recurrence in hepatocellular carcinoma (HCC) after liver ...
BACKGROUND: We aimed to evaluate the risk of recurrence of hepatocellular carcinoma (HCC) after live...
Liver transplantation is the criterion standard treatment for hepatocellular carcinoma, but tumor re...
Background & Aims: Greater tumor aggressiveness and different management modalities of hepatocellula...
Greater tumor aggressiveness and different management modalities of hepatocellular cancer (HCC) befo...
HCC Recurrence after Liver Transplantation in Asia and Europe: Different Biology or Different Manage...
To identify prognostic factors after hepatocellular carcinoma (HCC) recurrence after liver transplan...
Liver transplantation (LT) is the treatment of choice for patients with unresectable early hepatocel...
BACKGROUND: Liver transplantation (LT) is a curative treatment for hepatocellular carcinoma (HCC) an...
International audienceAIM: To assess pre-orthotopic liver transplantation (OLT) factors that could b...
Objective: Liver transplantation (LT) is known to be a promising treatment for patients with liver c...
SummaryObjectiveLiver transplantation (LT) is known to be a promising treatment for patients with li...
Aim: Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and liver ...
BACKGROUND: This study aimed to classify transplantable recurrent hepatocellular carcinoma (HCC) aft...
Background: Prognostic factors for hepatocellular carcinoma (HCC) recurrence after liver transplanta...
Background: Risk factors of early and late recurrence in hepatocellular carcinoma (HCC) after liver ...
BACKGROUND: We aimed to evaluate the risk of recurrence of hepatocellular carcinoma (HCC) after live...
Liver transplantation is the criterion standard treatment for hepatocellular carcinoma, but tumor re...
Background & Aims: Greater tumor aggressiveness and different management modalities of hepatocellula...
Greater tumor aggressiveness and different management modalities of hepatocellular cancer (HCC) befo...
HCC Recurrence after Liver Transplantation in Asia and Europe: Different Biology or Different Manage...
To identify prognostic factors after hepatocellular carcinoma (HCC) recurrence after liver transplan...
Liver transplantation (LT) is the treatment of choice for patients with unresectable early hepatocel...
BACKGROUND: Liver transplantation (LT) is a curative treatment for hepatocellular carcinoma (HCC) an...
International audienceAIM: To assess pre-orthotopic liver transplantation (OLT) factors that could b...
Objective: Liver transplantation (LT) is known to be a promising treatment for patients with liver c...
SummaryObjectiveLiver transplantation (LT) is known to be a promising treatment for patients with li...
Aim: Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and liver ...
BACKGROUND: This study aimed to classify transplantable recurrent hepatocellular carcinoma (HCC) aft...
Background: Prognostic factors for hepatocellular carcinoma (HCC) recurrence after liver transplanta...
Background: Risk factors of early and late recurrence in hepatocellular carcinoma (HCC) after liver ...
BACKGROUND: We aimed to evaluate the risk of recurrence of hepatocellular carcinoma (HCC) after live...
Liver transplantation is the criterion standard treatment for hepatocellular carcinoma, but tumor re...